Three Amigos Stock Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ken W who wrote (27888)	1/21/2002 12:02:49 PM
From: Sergio H	Read Replies (1) of 29382

Hi Ken. I've been looking over medical and biotech stocks. Some comments: First, on the two I already own, EXAC is a lay-up right now for a trader or an investor. CLGY is going to be a barn burner second quarter this year. Looking over your CDIC, I noticed that Doug and the 56ers are following this stock. I need a decoder ring to understand the jargon: Message 16939097 How about taking a fresh TA look at DFIB? It took a break on 25 million new share dilution but there's plenty of catalyctic conbustion such as new hospital deals, increasing international sales and pending FDA approval of RYTHMX software. Two other med stocks worth a look, BSMD and VITX. BSMD was mentioned by Crossy. I think that it's a timely play. Earnings are coming up, and they should be better than expected due to the roll-out of Embo-Gold, a high margin product covered by blue cross/blue shield. VITX is pending FDA approval to enter Phase III trials for onactivasion of red blood cells. This approval kicks in a $4 million dollar equity investment. Looking at the chart, VITX looks good for a bottom Bollinger bounce. On MTNT, I haven't been ignoring discussing this stock because it has ended up badly. I am going to hold it until the end of the year and if its still a loser, I'll sell it to offset gains. Can't win them all. Interesting article on Value Line Emerging Opportunities Fund. Portfolio selection is made on more of a technical bend than fundamental. Reminded me of you. An excerpt from the article: <I don't think I can do much better than come back to what I was just saying. It's people [investors] that drive stock prices. No one can know all the fundamentals of a particular company. There's always going to be somebody who knows more than you. The best way of getting a look at where the stock is going to be going is to see where that money is going to be flowing. > thestreet.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next